3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionall...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GABOR SZENASI, LASZLO GABOR HARSING, GYULA SIMIG, NORA SZIRAY, ENDRENE FLORIAN, ISTVAN GACSALYI, RITA KAPILLERNE DEZSOFI, KRISZTINA MORICZ, BALAZS VOLK, KATALIN PALLAGI, TIBOR MEZEI, ANDRAS EGYED, JOZSEF BARKOCZY, CSILLA LEVELEKI, GYOERGY LEVAY, GABOR GIGLER
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GABOR SZENASI
LASZLO GABOR HARSING
GYULA SIMIG
NORA SZIRAY
ENDRENE FLORIAN
ISTVAN GACSALYI
RITA KAPILLERNE DEZSOFI
KRISZTINA MORICZ
BALAZS VOLK
KATALIN PALLAGI
TIBOR MEZEI
ANDRAS EGYED
JOZSEF BARKOCZY
CSILLA LEVELEKI
GYOERGY LEVAY
GABOR GIGLER
description The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or aryl optionally carrying one or two halogen substituent(s); R4 stands for alkyl having 1-7 carbon atom(s); R5 represents a group of the general Formula (II a) or (II b), wherein Q and W each represents nitrogen or CH; R6, R7 and R8 each stands for hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R6 and R7 together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which are useful in the treatment or prophylaxis of diseases of the central nervous system, the gastrointestinal system and the cardiovascular system.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT1776339EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT1776339EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT1776339EE3</originalsourceid><addsrcrecordid>eNqNzDFqAzEQBdBtUgQnd5hyDZlirWDjUqxmkYhWI0bjhXVjTFCqkBjsA_mosUkOkOr9D5__2FwNtm37itlTmuMSc8gkdh8SdnjvNr7dMb8BuxeDLvjZCePKY0iOI66QE4EjCZPVMFEBmxwIRavkoOcx8y65AgMLqCdQIasjJQUeoL8pNkIimXhXoMxFaQQXCsvtsjw1Dx_Hz3N9_nPRwEDae6yn70M9n47v9ateDlm7zWZtzJbI_GPyA8lJQ7M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS</title><source>esp@cenet</source><creator>GABOR SZENASI ; LASZLO GABOR HARSING ; GYULA SIMIG ; NORA SZIRAY ; ENDRENE FLORIAN ; ISTVAN GACSALYI ; RITA KAPILLERNE DEZSOFI ; KRISZTINA MORICZ ; BALAZS VOLK ; KATALIN PALLAGI ; TIBOR MEZEI ; ANDRAS EGYED ; JOZSEF BARKOCZY ; CSILLA LEVELEKI ; GYOERGY LEVAY ; GABOR GIGLER</creator><creatorcontrib>GABOR SZENASI ; LASZLO GABOR HARSING ; GYULA SIMIG ; NORA SZIRAY ; ENDRENE FLORIAN ; ISTVAN GACSALYI ; RITA KAPILLERNE DEZSOFI ; KRISZTINA MORICZ ; BALAZS VOLK ; KATALIN PALLAGI ; TIBOR MEZEI ; ANDRAS EGYED ; JOZSEF BARKOCZY ; CSILLA LEVELEKI ; GYOERGY LEVAY ; GABOR GIGLER</creatorcontrib><description>The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or aryl optionally carrying one or two halogen substituent(s); R4 stands for alkyl having 1-7 carbon atom(s); R5 represents a group of the general Formula (II a) or (II b), wherein Q and W each represents nitrogen or CH; R6, R7 and R8 each stands for hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R6 and R7 together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which are useful in the treatment or prophylaxis of diseases of the central nervous system, the gastrointestinal system and the cardiovascular system.</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090916&amp;DB=EPODOC&amp;CC=PT&amp;NR=1776339E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090916&amp;DB=EPODOC&amp;CC=PT&amp;NR=1776339E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GABOR SZENASI</creatorcontrib><creatorcontrib>LASZLO GABOR HARSING</creatorcontrib><creatorcontrib>GYULA SIMIG</creatorcontrib><creatorcontrib>NORA SZIRAY</creatorcontrib><creatorcontrib>ENDRENE FLORIAN</creatorcontrib><creatorcontrib>ISTVAN GACSALYI</creatorcontrib><creatorcontrib>RITA KAPILLERNE DEZSOFI</creatorcontrib><creatorcontrib>KRISZTINA MORICZ</creatorcontrib><creatorcontrib>BALAZS VOLK</creatorcontrib><creatorcontrib>KATALIN PALLAGI</creatorcontrib><creatorcontrib>TIBOR MEZEI</creatorcontrib><creatorcontrib>ANDRAS EGYED</creatorcontrib><creatorcontrib>JOZSEF BARKOCZY</creatorcontrib><creatorcontrib>CSILLA LEVELEKI</creatorcontrib><creatorcontrib>GYOERGY LEVAY</creatorcontrib><creatorcontrib>GABOR GIGLER</creatorcontrib><title>3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS</title><description>The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or aryl optionally carrying one or two halogen substituent(s); R4 stands for alkyl having 1-7 carbon atom(s); R5 represents a group of the general Formula (II a) or (II b), wherein Q and W each represents nitrogen or CH; R6, R7 and R8 each stands for hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R6 and R7 together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which are useful in the treatment or prophylaxis of diseases of the central nervous system, the gastrointestinal system and the cardiovascular system.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzDFqAzEQBdBtUgQnd5hyDZlirWDjUqxmkYhWI0bjhXVjTFCqkBjsA_mosUkOkOr9D5__2FwNtm37itlTmuMSc8gkdh8SdnjvNr7dMb8BuxeDLvjZCePKY0iOI66QE4EjCZPVMFEBmxwIRavkoOcx8y65AgMLqCdQIasjJQUeoL8pNkIimXhXoMxFaQQXCsvtsjw1Dx_Hz3N9_nPRwEDae6yn70M9n47v9ateDlm7zWZtzJbI_GPyA8lJQ7M</recordid><startdate>20090916</startdate><enddate>20090916</enddate><creator>GABOR SZENASI</creator><creator>LASZLO GABOR HARSING</creator><creator>GYULA SIMIG</creator><creator>NORA SZIRAY</creator><creator>ENDRENE FLORIAN</creator><creator>ISTVAN GACSALYI</creator><creator>RITA KAPILLERNE DEZSOFI</creator><creator>KRISZTINA MORICZ</creator><creator>BALAZS VOLK</creator><creator>KATALIN PALLAGI</creator><creator>TIBOR MEZEI</creator><creator>ANDRAS EGYED</creator><creator>JOZSEF BARKOCZY</creator><creator>CSILLA LEVELEKI</creator><creator>GYOERGY LEVAY</creator><creator>GABOR GIGLER</creator><scope>EVB</scope></search><sort><creationdate>20090916</creationdate><title>3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS</title><author>GABOR SZENASI ; LASZLO GABOR HARSING ; GYULA SIMIG ; NORA SZIRAY ; ENDRENE FLORIAN ; ISTVAN GACSALYI ; RITA KAPILLERNE DEZSOFI ; KRISZTINA MORICZ ; BALAZS VOLK ; KATALIN PALLAGI ; TIBOR MEZEI ; ANDRAS EGYED ; JOZSEF BARKOCZY ; CSILLA LEVELEKI ; GYOERGY LEVAY ; GABOR GIGLER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT1776339EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>GABOR SZENASI</creatorcontrib><creatorcontrib>LASZLO GABOR HARSING</creatorcontrib><creatorcontrib>GYULA SIMIG</creatorcontrib><creatorcontrib>NORA SZIRAY</creatorcontrib><creatorcontrib>ENDRENE FLORIAN</creatorcontrib><creatorcontrib>ISTVAN GACSALYI</creatorcontrib><creatorcontrib>RITA KAPILLERNE DEZSOFI</creatorcontrib><creatorcontrib>KRISZTINA MORICZ</creatorcontrib><creatorcontrib>BALAZS VOLK</creatorcontrib><creatorcontrib>KATALIN PALLAGI</creatorcontrib><creatorcontrib>TIBOR MEZEI</creatorcontrib><creatorcontrib>ANDRAS EGYED</creatorcontrib><creatorcontrib>JOZSEF BARKOCZY</creatorcontrib><creatorcontrib>CSILLA LEVELEKI</creatorcontrib><creatorcontrib>GYOERGY LEVAY</creatorcontrib><creatorcontrib>GABOR GIGLER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GABOR SZENASI</au><au>LASZLO GABOR HARSING</au><au>GYULA SIMIG</au><au>NORA SZIRAY</au><au>ENDRENE FLORIAN</au><au>ISTVAN GACSALYI</au><au>RITA KAPILLERNE DEZSOFI</au><au>KRISZTINA MORICZ</au><au>BALAZS VOLK</au><au>KATALIN PALLAGI</au><au>TIBOR MEZEI</au><au>ANDRAS EGYED</au><au>JOZSEF BARKOCZY</au><au>CSILLA LEVELEKI</au><au>GYOERGY LEVAY</au><au>GABOR GIGLER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS</title><date>2009-09-16</date><risdate>2009</risdate><abstract>The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or aryl optionally carrying one or two halogen substituent(s); R4 stands for alkyl having 1-7 carbon atom(s); R5 represents a group of the general Formula (II a) or (II b), wherein Q and W each represents nitrogen or CH; R6, R7 and R8 each stands for hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R6 and R7 together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which are useful in the treatment or prophylaxis of diseases of the central nervous system, the gastrointestinal system and the cardiovascular system.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT1776339EE
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title 3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A41%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GABOR%20SZENASI&rft.date=2009-09-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT1776339EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true